Lakefront Biotherapeutics (GXEA) Cash flow

0 Followers

Lakefront Biotherapeutics Cash Flow

DE:GXEA's free cash flow for Q2 2026 was €0.00. For the 2026 fiscal year, DE:GXEA's free cash flow was decreased by €130.82M and operating cash flow was €0.00. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	€ -257.46M	€ -320.03M	€ -405.97M	€ -500.54M	€ -503.83M
Investing Cash Flow	€ 288.81M	€ 220.60M	€ 71.19M	€ -1.25B	€ 541.24M
Financing Cash Flow	€ -3.27M	€ -4.92M	€ -5.00M	€ -1.49M	€ -3.88M
End Cash Position	€ 87.87M	€ 64.24M	€ 166.81M	€ 508.12M	€ 2.23B
Free Cash Flow	€ -271.31M	€ -402.14M	€ -425.24M	€ -537.49M	€ -561.71M

Currency in EUR